Il y a eu 50 transactions d'initiés récentes enregistrées pour Pfizer Inc. (PFE), dont 29 achats et 21 ventes. Le total des achats d'initiés s'élève à $64.79M et le total des ventes d'initiés à $33.15M.
Les initiés notables ayant une activité récente comprennent Boshoff Christoffel, Mcdermott Michael, Bourla Albert. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — PFE
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2030-02-23 |
Boshoff Christoffel |
Executive Vice President |
Cession |
17,984 |
$42.30 |
$760.72K |
- |
| 2029-02-24 |
Boshoff Christoffel |
Executive Vice President |
Cession |
10,222 |
$45.96 |
$469.8K |
- |
| 2028-02-25 |
Boshoff Christoffel |
Executive Vice President |
Cession |
16,688 |
$33.82 |
$564.39K |
- |
| 2028-02-25 |
Mcdermott Michael |
Executive Vice President |
Cession |
32,769 |
$33.82 |
$1.11M |
- |
| 2027-02-27 |
Boshoff Christoffel |
Executive Vice President |
Cession |
21,127 |
$31.31 |
$661.49K |
- |
| 2027-02-27 |
Mcdermott Michael |
Executive Vice President |
Cession |
41,485 |
$31.31 |
$1.3M |
- |
| 2026-03-31 |
Bourla Albert |
Chairman & CEO |
Attribution de RSU |
21 |
- |
- |
759,049 |
| 2026-03-27 |
Narayen Shantanu |
Director |
Attribution de RSU |
1,849 |
- |
- |
187,925 |
| 2026-03-27 |
Taraporevala Cyrus |
Director |
Attribution de RSU |
1,387 |
- |
- |
27,140 |
| 2026-03-27 |
Quincey James |
Director |
Attribution de RSU |
1,433 |
- |
- |
77,318 |
| 2026-03-27 |
Smith James C |
Director |
Attribution de RSU |
1,664 |
- |
- |
170,425 |
| 2026-03-27 |
Echevarria Joseph |
Director |
Attribution de RSU |
1,710 |
- |
- |
153,398 |
| 2026-03-27 |
Buckley Mortimer J |
Director |
Attribution de RSU |
1,387 |
- |
- |
16,705 |
| 2026-03-13 |
Bourla Albert |
Chairman & CEO |
Attribution de RSU |
1,630 |
- |
- |
759,400 |
| 2026-03-04 |
Damico Jennifer B. |
SVP & Controller |
Retenue Fiscale RSU |
826 |
$26.62 |
$21.99K |
32,934 |
| 2026-03-03 |
Denton David M |
Chief Financial Officer & EVP |
Attribution de RSU |
216,537 |
$26.58 |
$5.76M |
216,537 |
| 2026-03-03 |
Fonseca Lidia |
Executive Vice President |
Attribution de RSU |
82,284 |
$26.58 |
$2.19M |
82,284 |
| 2026-03-03 |
Lankler Douglas M |
Executive Vice President |
Attribution de RSU |
194,883 |
$26.58 |
$5.18M |
194,883 |
| 2026-03-03 |
Bourla Albert |
Chairman & CEO |
Attribution de RSU |
708,666 |
$26.58 |
$18.84M |
708,666 |
| 2026-03-03 |
Damico Jennifer B. |
SVP & Controller |
Attribution de RSU |
22,638 |
$26.58 |
$601.72K |
22,638 |
| 2026-03-03 |
Sahni Payal |
Executive Vice President |
Attribution de RSU |
108,268 |
$26.58 |
$2.88M |
108,268 |
| 2026-03-03 |
Malik Aamir |
Executive Vice President |
Attribution de RSU |
194,883 |
$26.58 |
$5.18M |
194,883 |
| 2026-03-03 |
Mcdermott Michael |
Executive Vice President |
Attribution de RSU |
151,576 |
$26.58 |
$4.03M |
151,576 |
| 2026-03-03 |
Boshoff Christoffel |
President, R&d |
Attribution de RSU |
259,844 |
$26.58 |
$6.91M |
259,844 |
| 2026-03-03 |
De Germay Alexandre |
Executive Vice President |
Attribution de RSU |
194,883 |
$26.58 |
$5.18M |
194,883 |
| 2026-03-03 |
Baum Andrew |
Executive Vice President |
Attribution de RSU |
303,151 |
$26.58 |
$8.06M |
303,151 |
| 2026-02-28 |
Boshoff Christoffel |
Executive Vice President |
Cession |
12,009 |
$38.71 |
$464.87K |
- |
| 2026-02-28 |
Mcdermott Michael |
Executive Vice President |
Cession |
16,011 |
$38.71 |
$619.79K |
- |
| 2026-02-27 |
Damico Jennifer B. |
SVP & Controller |
Retenue Fiscale RSU |
655 |
$27.65 |
$18.11K |
12,041 |
| 2026-02-26 |
Mcdermott Michael |
Executive Vice President |
Retenue Fiscale RSU |
3,503 |
$27.10 |
$94.93K |
74,308 |
| 2026-02-25 |
Fonseca Lidia |
Executive Vice President |
Exercice d'Options (Vente) |
56,888 |
$33.82 |
$1.92M |
- |
| 2026-02-25 |
Lankler Douglas M |
Executive Vice President |
Exercice d'Options (Vente) |
122,907 |
$33.82 |
$4.16M |
- |
| 2026-02-25 |
Bourla Albert |
Chairman & CEO |
Exercice d'Options (Vente) |
491,626 |
$33.82 |
$16.63M |
- |
| 2026-02-25 |
Damico Jennifer B. |
SVP & Controller |
Exercice d'Options (Vente) |
17,558 |
$33.82 |
$593.81K |
- |
| 2026-02-25 |
Sahni Payal |
Executive Vice President |
Exercice d'Options (Vente) |
56,888 |
$33.82 |
$1.92M |
- |
| 2026-02-25 |
Mcdermott Michael |
Executive Vice President |
Exercice d'Options (Vente) |
37,925 |
$33.82 |
$1.28M |
- |
| 2026-02-25 |
Boshoff Christoffel |
President, R&d |
Retenue Fiscale RSU |
6,833 |
$27.09 |
$185.11K |
161,379 |
| 2026-02-23 |
Damico Jennifer B. |
SVP & Controller |
Retenue Fiscale RSU |
419 |
$27.06 |
$11.34K |
12,186 |
| 2026-02-23 |
Boshoff Christoffel |
President, R&d |
Retenue Fiscale RSU |
816 |
$27.06 |
$22.08K |
154,829 |
| 2026-02-12 |
Bourla Albert |
Chairman & CEO |
Attribution de RSU |
2,883 |
- |
- |
757,286 |
| 2026-01-30 |
Boshoff Christoffel |
President, R&d |
Retenue Fiscale RSU |
12,887 |
$26.44 |
$340.73K |
155,645 |
| 2026-01-14 |
Bourla Albert |
Chairman & CEO |
Attribution de RSU |
79 |
- |
- |
743,136 |
| 2025-12-31 |
Narayen Shantanu |
Director |
Attribution de RSU |
2,008 |
- |
- |
183,164 |
| 2025-12-31 |
Taraporevala Cyrus |
Director |
Attribution de RSU |
1,506 |
- |
- |
25,350 |
| 2025-12-31 |
Quincey James |
Director |
Attribution de RSU |
1,556 |
- |
- |
74,697 |
| 2025-12-31 |
Bourla Albert |
Chairman & CEO |
Attribution de RSU |
24 |
- |
- |
743,147 |
| 2025-12-31 |
Smith James C |
Director |
Attribution de RSU |
1,807 |
- |
- |
166,120 |
| 2025-12-31 |
Echevarria Joseph |
Director |
Attribution de RSU |
1,857 |
- |
- |
149,314 |
| 2025-12-31 |
Buckley Mortimer J |
Director |
Attribution de RSU |
1,506 |
- |
- |
15,078 |
| 2025-12-15 |
Bourla Albert |
Chairman & CEO |
Attribution de RSU |
23 |
- |
- |
742,986 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi